Computational Biology Market Size & Share, by Application (Cellular & Biological Simulation, Drug Discovery, Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation); Component (Databases, Infrastructure Hardware, Analysis Services); End-user (Academics, Industrial, Commercials) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3921
  • Published Date: May 30, 2023
  • Report Format: PDF, PPT

Companies dominating the Global Computational Biology Landscape

    • Dassault Systèmes SE
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Certara Inc.
    • Instem Group
    • Compugen
    • Chemical Computing Group ULC
    • Rhenovia Pharma SAS
    • Nimbus Discovery LLC
    • Rhenovia Pharma SAS
    • Insilico Biotechnology AG
    • Genedata AG

Browse Key Market Insights with Data Illustration:


In The News

Certara Inc. announced that the U.S. Food and Drug Administration (FDA) has renewed and expanded the company’s licenses of Certra’s proprietarybiosimulation software along with other 400 user licenses of Phoenix software and Simcyp.

Instem Group declared the acquisition of Edge Software Consultancy Ltd to expand its portfolio to discover R&D activities thereby bringing the client products into the market at a faster rate. The technology and services of the Edge helped to enhance the research and development activities of drug discovery and increased client productivity.


Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3921
  • Published Date: May 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing investment in research and development activities and growing demand for bioinformatics are the major factors driving the market growth.

The market size of computational biology is anticipated to attain a CAGR of ~20% over the forecast period, i.e., 2023-2035.

Lack of enough researchers and dearth of trained professionals are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Certara Inc., Instem Group, Compugen, Chemical Computing Group ULC, Rhenovia Pharma SAS, Nimbus Discovery LLC, Rhenovia Pharma SAS, Insilico Biotechnology AG, Genedata AG, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, component, end-user, and by region.

The commercial segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying